This continuing education activity is designed to enable the learner to understand the challenges of working in oncology and how they can maintain a healthy work-life balance.
Palbociclib (Ibrance®) is an oral therapy for postmenopausal women with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer.
Panobinostat (Farydak ®) is an oral chemotherapy given in combination with other medications for the treatment of several types of cancers.
Oncology patients may need the care of an Intensive Care Unit (ICU) and this unfamiliar environment can cause a great deal of stress for the oncology patient and/or family.
It’s summertime - that means fun, sun and vacations! Just because you are going through cancer treatment doesn’t mean you can’t take a vacation. Watch the Cancer Goes to the Beach webinar to get tips and resources to plan a safe and stress free getaway. July is also UV Safety Month – learn all you need to know to stay sun safe this summer.
Jul 3, 2015
Reduction in inflammatory biomarkers among women with BMI >25 kg/m², low serum 25(OH)D
Jul 3, 2015
Lower average relative dose intensity linked to worse overall and ovarian cancer-specific survival
Jul 2, 2015
Jul 1, 2015
No differences in blood loss, complication rates, survival for morbidly obese, lower-weight patients
Our award winning cancer education content is now available for licensing and syndication.
Please help us to better understand skin cream usage for patients who develop skin redness/irritation during radiation therapy. We are very interested in the opinions and experience of both patients and providers regarding skin cream usage for radiation-related skin reactions. Your participation in this survey would be much appreciated.